Therefore, we conclude that targeting C5aR1- and TLR4-involved signaling pathway is efficacious to treat I/R-induced brain injury in rats with the neuroprotective agent isoquercetin as shown in Figure 8H. This evidence concerns the gene TLR4 and injury.